Evidence map›Paper›PMID 30123509›Full record

ArticleJournal of intensive care2018

The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Kent Doi, Osamu Nishida, Takashi Shigematsu, Tomohito Sadahiro, Noritomo Itami, Kunitoshi Iseki, Yukio Yuzawa, Hirokazu Okada, Daisuke Koya, Hideyasu Kiyomoto and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of intensive care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kent Doi1Department of Acute Medicine, The University of Tokyo, Tokyo, Japan.
Osamu Nishida2Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, Toyoake, Aichi Japan.
Takashi Shigematsu3Department of Nephrology, Wakayama Medical University, Wakayama, Japan.
Tomohito Sadahiro4Department of Emergency and Critical Care Medicine, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Noritomo Itami5Kidney Center, Department of Surgery, Nikko Memorial Hospital, Hokkaido, Japan.
Kunitoshi Iseki6Clinical Research Support Center, Tomishiro Central Hospital, Okinawa, Japan.
Yukio Yuzawa7Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi Japan.
Hirokazu Okada8Department of Nephrology and General Internal Medicine, Saitama Medical University, Saitama, Japan.
Daisuke Koya9Division of Anticipatory Molecular Food Science and Technology, Department of Diabetology and Endocrinology, Kanazawa Medical University, Kanawaza, Ishikawa Japan.
Hideyasu Kiyomoto10Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Yugo Shibagaki11Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Kanagawa Japan.
Kenichi Matsuda12Department of Emergency and Critical Care Medicine, University of Yamanashi School of Medicine, Yamanashi, Japan.
Akihiko Kato13Blood Purification Unit, Hamamatsu University Hospital, Hamamatsu, Japan.
Terumasa HayashiDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
Tomonari Ogawa15Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Tatsuo Tsukamoto16Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eisei Noiri17Department of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
Shigeo Negi3Department of Nephrology, Wakayama Medical University, Wakayama, Japan.
Koichi Kamei18Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Hirotsugu Kitayama19Department of Nephrology, Shizuoka Children's Hospital, Shizuoka, Japan.
Naoki Kashihara20Department of Nephrology and Hypertension, Kawasaki Medical School, Okayama, Japan.
Toshiki Moriyama21Health Care Division, Health and Counseling Center, Osaka University, Osaka, Japan.
Yoshio Terada22Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, 783-8505 Japan.
Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.

Indexed as

Acute kidney injuryAtrial natriuretic peptideBiomarkerBlood purificationLong-term follow-upNafamostat mesilate

Identifiers

PMID30123509
PMCPMC6088399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.